Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Mirum Pharmaceuticals, Inc.

NASDAQ: MIRM · Life Sciences · 9 alerts · CIK 1759425

Mirum Pharmaceuticals, Inc. stories on ALFA USA NewsRead the news →
Share price
$91.58Close, Nov 16
Market cap
$5.98B
Shares outstanding
65.28MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Mirum Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:07 PM ET 10-Q
Financial Results ▶ Call

Mirum Pharmaceuticals Q3 2026 Results: Net Loss of $40.8M

Mirum Pharmaceuticals reported a significant net loss of $898.1 million for the nine months ended September 30, 2026, primarily driven by $756.2 million in acquired in-process research and development expenses. Despite the loss, net product sales grew to $521.8 million for the same period, up from $372.4 million in the prior year.

Key figure
Net loss $40.8M
4:04 PM ET 8-K
Financial Results

Mirum Pharmaceuticals Financial Results

Mirum Pharmaceuticals reported Q3 2026 net product sales of $185.7 million, driven by strong performance from LIVMARLI and Bile Acid Medicines. The company increased its full-year 2026 net product sales guidance to a range of $715 million to $720 million following the FDA approval and launch of ATEBRIOZ for FOP.

“The third quarter was an important period of execution for Mirum, with the approval and launch of ATEBRIOZ and positive Phase 3 results across our late-stage rare liver portfolio. Positive results from AZURE-1 and additional data we’ll be sharing at AASLD reinforce the potential of brelovitug to become an important new treatment for chronic HDV, while EXPAND results support the potential to bring LIVMARLI to more patients living with rare cholestatic liver diseases, including biliary atresia.”

Chris Peetz, Chief Executive Officer of Mirum

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.